PHVS
PharvarisCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
Current thesis
Composite grade C from latest DB weights. Momentum 67.3 / Value 41.1
Posture
Mixed
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta -2.7.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
67
Value
41
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-05-28 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $45.63
Why
Momentum67 · Δ7d -2.7
Value41 · Δ7d +0.1
SentimentN/A · Δ7d -
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Momentum · See technicals
Momentum
67
52% active weight
Current posture
7d trendImproving
Δ7d
-2.7
Δ21d
+0.3
Value
41
48% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
+0.2
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade C. Momentum 67.3 / Value 41.1
Fundamentals (TTM)As of 2026-05-28
Fundamentals (TTM)
As of 2026-05-28
Market Cap
$2.07B
Beta
-2.78
Shares Out
64.96M
P/E (TTM) · Derived
-10.0
P/S (TTM)
-
P/FCF (TTM) · Derived
-12.10
Rev YoY
-
EPS YoY
+22.7%
Gross Margin
-
Op Margin
-
Net Debt
-$302.82M
Current Ratio
12.86
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology